INNOVATIVE IDEAS ON THE WAY TO MARKET.

Build on the findings of cutting-edge life science research, MAxL is home of currently 12 pre-seed and early-stage teams.

MAxL offers these teams support, infrastructure and the time to develop their ideas into market-ready products.

MAxL - IN A NUTSHELL.

Where:

- on around 900 m² in close proximity to BioM - since mid-2024^M - seit Mitte 2024

What:

- Innovative therapeutics (all forms, including ATMPs such as gene therapy, cell therapy, vaccines)

- Platform technologies for the discovery and development of drugs and for the production of drugs and vaccines

- Next-generation diagnostics and diagnostic platforms

- Health tech business models based on digital health, big data, machine learning and AI

- Biotechnology-based solutions in the field of bioeconomy

How:

- Access to state-of-the-art laboratory infrastructure (including equipment), co-working and event space

- Individual and close support for the founding teams to further develop their technology and business model (incubation)

- Coaching and mentoring by experienced entrepreneurs and experts

- Access to the broad Bio^M network of start-ups, industry partners, investors, clinics and academic partners

- Training programs tailored to bioentrepreneurs

- Wide range of events for the MAxL community